Canada markets closed

Vaccinex, Inc. (VCNX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
5.75+0.05 (+0.88%)
At close: 04:00PM EDT
6.00 +0.25 (+4.35%)
After hours: 06:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 9.11M
Enterprise Value 7.82M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.68
Price/Book (mrq)3.05
Enterprise Value/Revenue 276.08
Enterprise Value/EBITDA -0.72

Trading Information

Stock Price History

Beta (5Y Monthly) 0.74
52-Week Change 3-93.15%
S&P500 52-Week Change 326.27%
52 Week High 3100.80
52 Week Low 34.43
50-Day Moving Average 36.80
200-Day Moving Average 317.45

Share Statistics

Avg Vol (3 month) 313.02k
Avg Vol (10 day) 35.19k
Shares Outstanding 51.58M
Implied Shares Outstanding 61.67M
Float 8591.01k
% Held by Insiders 16.77%
% Held by Institutions 141.49%
Shares Short (Apr 30, 2024) 412.99k
Short Ratio (Apr 30, 2024) 41.27
Short % of Float (Apr 30, 2024) 41.57%
Short % of Shares Outstanding (Apr 30, 2024) 40.82%
Shares Short (prior month Mar 28, 2024) 46.28k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:14
Last Split Date 3Feb 20, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,014.91%

Management Effectiveness

Return on Assets (ttm)-246.44%
Return on Equity (ttm)-1,405.34%

Income Statement

Revenue (ttm)570k
Revenue Per Share (ttm)1.23
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
EBITDA -22.77M
Net Income Avi to Common (ttm)-20.25M
Diluted EPS (ttm)-43.68
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.53M
Total Cash Per Share (mrq)1.25
Total Debt (mrq)247k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.57
Book Value Per Share (mrq)-2.59

Cash Flow Statement

Operating Cash Flow (ttm)-17.23M
Levered Free Cash Flow (ttm)-11.11M